D. Deligözoğlu Et Al. , "Can we use copeptin as a biomarker for masked hypertension or metabolic syndrome in obese children and adolescents?," Journal of Pediatric Endocrinology and Metabolism , vol.33, no.12, pp.1551-1561, 2020
Deligözoğlu, D. Et Al. 2020. Can we use copeptin as a biomarker for masked hypertension or metabolic syndrome in obese children and adolescents?. Journal of Pediatric Endocrinology and Metabolism , vol.33, no.12 , 1551-1561.
Deligözoğlu, D., Kasap-Demir, B., Alparslan, C., Erbak, H., Çatlı, G., Mutlubaş, F., ... Alaygut, D.(2020). Can we use copeptin as a biomarker for masked hypertension or metabolic syndrome in obese children and adolescents?. Journal of Pediatric Endocrinology and Metabolism , vol.33, no.12, 1551-1561.
Deligözoğlu, Duygu Et Al. "Can we use copeptin as a biomarker for masked hypertension or metabolic syndrome in obese children and adolescents?," Journal of Pediatric Endocrinology and Metabolism , vol.33, no.12, 1551-1561, 2020
Deligözoğlu, Duygu Et Al. "Can we use copeptin as a biomarker for masked hypertension or metabolic syndrome in obese children and adolescents?." Journal of Pediatric Endocrinology and Metabolism , vol.33, no.12, pp.1551-1561, 2020
Deligözoğlu, D. Et Al. (2020) . "Can we use copeptin as a biomarker for masked hypertension or metabolic syndrome in obese children and adolescents?." Journal of Pediatric Endocrinology and Metabolism , vol.33, no.12, pp.1551-1561.
@article{article, author={Duygu Deligözoğlu Et Al. }, title={Can we use copeptin as a biomarker for masked hypertension or metabolic syndrome in obese children and adolescents?}, journal={Journal of Pediatric Endocrinology and Metabolism}, year=2020, pages={1551-1561} }